Loading organizations...
Loading organizations...
Pharmaceutical company developing medicines for liver disease.
Versantis has raised $20.5M across 2 funding rounds.
Versantis has raised $20.5M in total across 2 funding rounds.
Versantis has raised $20.5M in total across 2 funding rounds.
Versantis's investors include Swisscanto Invest, Esperante, Michael Sidler, Verve Ventures, Robert Schier, Altus Partners, Lluis Pareras, OCCIDENT, Zürcher Kantonalbank.
Versantis has raised $20.5M across 2 funding rounds. Most recently, it raised $16.1M Series B in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 18, 2019 | $16.1M Series B | Swisscanto Invest | Esperante, Michael Sidler, Verve Ventures, Robert Schier |
| Mar 30, 2017 | $4.4M Series A | Michael Sidler | Altus Partners, Lluis Pareras, OCCIDENT, Zürcher Kantonalbank |